Patents by Inventor Isabel DÍAZ DEL CONSUELO

Isabel DÍAZ DEL CONSUELO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca)
    Publication number: 20160045440
    Abstract: The present invention relates to a dosage form which comprises amorphous calcium L-5-methylfolate and cysteine as stabilizing agent and optionally, further auxiliary agents. The dosage forms according to the invention resolves the problem of instability of amorphous calcium L-5-methylfolate to the oxidation by air.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 18, 2016
    Inventors: Gonzalo HERNANDEZ HERRERO, Celestino RONCHI, Isabel DÍAZ DEL CONSUELO
  • Sustained release formulations comprising GNRH analogues
    Patent number: 8962559
    Abstract: The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogs thereof and the manufacturing process of such pharmaceutical compositions.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: February 24, 2015
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Roland Cherif-Cheikh, Fédéric Lacombe, Maria-Luisa Torres Salgado, Perrine Cambriel, Mercé Cardus Malaspina, Isabel Diaz Del Consuelo, Martin Montes, Fabien Jeannerot, Marie Delporte, Anne Brochard, Joël Richard
  • SUSTAINED RELEASE FORMULATIONS COMPRISING GNRH ANALOGUES
    Publication number: 20150004210
    Abstract: The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogues thereof and the manufacturing process of such pharmaceutical compositions.
    Type: Application
    Filed: September 18, 2014
    Publication date: January 1, 2015
    Inventors: Roland CHERIF-CHEIKH, Fédéric LACOMBE, Maria-Luisa TORRES SALGADO, Perrine CAMBRIEL, Mercè CARDUS MALASPINA, Isabel DIAZ DEL CONSUELO, Martin MONTES, Fabien JEANNEROT, Marie DELPORTE, Anne BROCHARD, Joël RICHARD
  • SUSTAINED RELEASE FORMULATIONS COMPRISING GnRH ANALOGUES
    Publication number: 20120202743
    Abstract: The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogues thereof and the manufacturing process of such pharmaceutical compositions.
    Type: Application
    Filed: April 29, 2010
    Publication date: August 9, 2012
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Roland Cherif-Cheikh, Fédéric Lacombe, Maria-Luisa Torres Salgado, Perrine Cambriel, Mercé Cardus Malaspina, Isabel Diaz Del Consuelo, Martin Montes, Fabien Jeannerot, Marie Delporte, Anne Brochard, Joël Richard